Based on AI Trading Performance and Technical Analysis, $ABT has gained 16% over the last six months.
This AI trading robot from Swing Trader: Stocks from Consumer Sector (TA&FA), was a top performer in our robot factory over the 6 months, generating 16% for ABT.
Abbott Laboratories (NYSE: ABT), a multinational healthcare company, has experienced a significant 16% gain in its stock price over the past six months, outperforming expectations. This remarkable growth has been attributed to the AI trading robot from Swing Trader: Stocks from Consumer Sector (TA&FA), which generated strong returns for the company. The positive momentum has been further supported by bullish technical indicators, including the recent crossover of the 10-day moving average above the 50-day moving average.
AI Trading Robot Performance
The AI trading robot from Swing Trader: Stocks from Consumer Sector (TA&FA) has played a significant role in driving Abbott's gains. As a top performer in the robot factory, it has consistently outperformed the market, generating a 16% return for ABT over the past six months. This success demonstrates the potential of AI-driven trading strategies in identifying promising investment opportunities within the consumer sector, particularly in the healthcare industry.
Bullish Technical Indicators
On April 13, 2023, the 10-day moving average for ABT crossed bullishly above the 50-day moving average, signaling a shift in the trend and a potential buy opportunity. Historical data shows that in 12 out of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. This provides a 71% probability that the upward trend will continue, further bolstering the outlook for Abbott Laboratories.
The impressive performance of the AI trading robot and the bullish technical indicators suggest a positive outlook for Abbott Laboratories (ABT) in the coming months. Investors seeking exposure to the healthcare sector should consider ABT as a potential addition to their portfolios, given its recent performance and the likelihood of continued growth. However, it is essential to monitor market conditions and any company-specific news that may impact the stock price, as with any investment.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
ABT in +2.22% Uptrend, growing for three consecutive days on August 24, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where ABT advanced for three days, in of 303 cases, the price rose further within the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The Aroon Indicator entered an Uptrend today. In of 263 cases where ABT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Bearish Trend Analysis
The 10-day RSI Indicator for ABT moved out of overbought territory on August 26, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Momentum Indicator moved below the 0 level on August 31, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ABT as a result. In of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for ABT turned negative on August 26, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 55 similar instances when the indicator turned negative. In of the 55 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ABT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.687) is normal, around the industry mean (10.936). P/E Ratio (35.252) is within average values for comparable stocks, (69.171). Projected Growth (PEG Ratio) (1.999) is also within normal values, averaging (3.895). Dividend Yield (0.023) settles around the average of (0.017) among similar stocks. P/S Ratio (4.083) is also within normal values, averaging (36.639).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ABT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ABT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a manufacturer of health care products
Industry MedicalNursingServices
Advertisement